Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Background Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer's disease have not been extensively investigated in longitudinal studies. Methods We conducted a multicenter, nested case-control study of Alzheimer's disease biomarkers in cognitively normal participants who were enrolled in the China Cognition and Aging Study from January 2000 through December 2020. A subgroup of these participants underwent testing of cerebrospinal fluid (CSF), cognitive assessments, and brain imaging at 2-year-to-3-year intervals. A total of 648 participants in whom Alzheimer's disease developed were matched with 648 participants who had normal cognition, and the temporal trajectories of CSF biochemical marker concentrations, cognitive testing, and imaging were analyzed in the two groups. Results The median follow-up was 19.9 years (interquartile range, 19.5 to 20.2). CSF and imaging biomarkers in the Alzheimer's disease group diverged from those in the cognitively normal group at the following estimated number of years before diagnosis: amyloid-beta (Aβ) 42 , 18 years; the ratio of Aβ 42 to Aβ 40 , 14 years; phosphorylated tau 181, 11 years; total tau, 10 years; neurofilament light chain, 9 years; hippocampal volume, 8 years; and cognitive decline, 6 years. As cognitive impairment progressed, the changes in CSF biomarker levels in the Alzheimer's disease group initially accelerated and then slowed. Conclusions In this study involving Chi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study indicated that within 20 years, abnormalities in CSF Aβ42, the ratio of CSF Aβ42 to Aβ40, CSF P-tau181, CSF T-tau, CSF neurofilament light chain (NfL), and hippocampal volume (as detected by sMRI) appear in sequence before the clinical diagnosis of SAD.375”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [375]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Measuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,818
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Vrieze, S. I. (2012) · Psychological Methods · doi:10.1037/a0027127 · Cited by 1,948
Mild cognitive impairment: a concept in evolution
Petersen, R. C., Caracciolo, B., Brayne, C., Gauthier, S., Jelic, V., & Fratiglioni, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12190 · Cited by 1,694
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610
Cited by
Items 101–200 of 488
Ding, X., Yang-Fan, Z. U. O., Liu, Z., Sun, Y., Wang, L., Xie, Y., Liu, G., & Liu, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139359 · Cited by 11
Remote cognitive tests predict neurodegenerative biomarkers in the Insight 46 cohort
Giovane, M. D., Giunchiglia, V., Cai, Z., Leoni, M., Street, R. E., Lu, K., Wong, A., Popham, M., Nicholas, J. M., Trender, W. R., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14572 · Cited by 14
Genetic and circulating biomarkers of cognitive dysfunction and dementia in CKD
Zoccali, C., Mallamaci, F., Wagner, C. A., Unwin, R. J., Nedergaard, M., Hafez, G., Małyszko, J., Pépin, M., Massy, Z. A., Paolisso, G., et al. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae259 · Cited by 12
Tang, P., Zhao, D., Lin, H., Li, X., Shi, C., Li, P., & Chen, H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115489 · Cited by 12
Yang, Y., Diao, Y., Jiang, L., Li, F., Chen, L., Ni, M., Wang, Z., & Fang, H. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.018 · Cited by 11
Self-citationMRI-to-PET synthesis via deep learning for amyloid-β quantification in Alzheimer’s disease
Chen, Z., Bi, S., Yi, S., Wang, F., Wang, Y., Qi, Z.-Y., Wang, T., Li, X., Li, S.-N., Xiao, H., et al. (2026) · European Radiology · doi:10.1007/s00330-025-12251-3 · Cited by 12
Self-citationIrmen, R. E., Turner, S. M., Snipes, J. A., Schloss, K. H., Wang, X., Williams, H. C., Velmurugan, G. V., Hunt, J. B., Li, J., Sullivan, P. G., et al. (2026) · npj Dementia · doi:10.1038/s44400-025-00054-8 · Cited by 12
Musso, G., Gabelli, C., Puthenparampil, M., Cosma, C., Cagnin, A., Gallo, P., Sorarú, G., Pegoraro, E., Zaninotto, M., Antonini, A., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120014 · Cited by 11
Alzheimer’s Disease Biomarkers — Timing Is Everything
Mayeux, R. P. (2024) · New England Journal of Medicine · doi:10.1056/nejme2400102 · Cited by 11
Dai, Q., Ma, Y., Liu, C., Zhao, R., Chen, Q., Chen, W., Wang, X., Jiang, X., & Li, S. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-04943-0 · Cited by 10
Chaulagain, B., & Singh, J. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00811 · Cited by 11
Hou, M., & Yang, L. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1616232 · Cited by 12
Wang, M., Zhang, L., Huang, W., Huang, J., Luo, Y., & Huang, N. (2025) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2025.103222 · Cited by 10
Chen, S., Ou, R., Wei, Q., Fu, J., Zhao, B., Chen, X., & Shang, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14503 · Cited by 11
Self-citationMicrobiome: A Key Regulator of Body-Brain Interactions
O’Riordan, K. J., Aburto, M. R., Nagpal, J. K., Clarke, G. A., & Cryan, J. F. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-89525-8_6 · Cited by 10
Natural history of Chiari I malformation-syringomyelia: longitudinal cohort study
Yuan, C., Du, Y., Yao, Q., Zhang, C., Zhang, L., Liu, Z., Wang, K., Duan, W., Wang, Z., Wang, X., et al. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2025-336023 · Cited by 9
Proteomics-based aging clocks in midlife or late-life and their associated risk of dementia
Sedaghat, S., Park, S., Walker, R. F., Wang, S., Liu, J., Hughes, T. M., Sabayan, B., Tang, W., Coresh, J., Pankow, J. S., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01096-y · Cited by 10
Self-citationChen, L., Xia, Y., Li, B., Jh, G., Zhou, X., Li, X., Chen, Z., Liu, Y., Mao, W., Zhang, J., et al. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.139065 · Cited by 9
Self-citationPorta‐Mas, C., Grau‐Rivera, O., Gispert, J. D., Blasco, G. S., & Sánchez‐Benavides, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70753 · Cited by 9
Khan, A., Shen, J., Zahid, A., Hu, C., Xu, X., & Cheng, X. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c21679 · Cited by 9
Greenberg, S. M. (2026) · New England Journal of Medicine · doi:10.1056/nejmra2411298 · Cited by 10
Hydroxygenkwanin exerts a neuroprotective effect by activating the Nrf2/ARE signaling pathway
Osama, A., Wu, J., Nie, Q., Song, Z., Zhang, L., Gao, J., & Zhang, B. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.114842 · Cited by 9
Walter, S., Langford, O., Jimenez‐Maggiora, G. A., Abdel‐Latif, S., Rissman, R. A., Grill, J. D., Karlawish, J. H., Atri, A., Bruschi, S., Hussen, K., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.101 · Cited by 8
Bu, X., Zhu, W., Wang, Q.-H., Liu, Z., Bao, Y.-Y., Bai, Y., Li, J.-H., Liu, Z.-H., Zhao, J.-L., Xiang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60748-8 · Cited by 9
Self-citationLower odor identification in subjective cognitive decline: a meta‐analysis
Jobin, B., Zigrand, C., Frasnelli, J., Boller, B., & Albers, M. W. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70168 · Cited by 12
Leone, R., Kobeleva, X., Rowe, B., Choupan, J., Ringman, J. M., & Barisano, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70588 · Cited by 8
Biel, D., Steward, A., Dewenter, A., Dehsarvi, A., Zhu, Z., Roemer, S. N., Frontzkowski, L. K., Hirsch, F., Palleis, C., Höglinger, G. U., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70783 · Cited by 10
Xue, H., Bi, S., Chen, Z., He, Y., Xu, W., Xu, X., Cui, B., Hu, Y., Qi, Z., Yan, S., et al. (2025) · EJNMMI Research · doi:10.1186/s13550-025-01339-y · Cited by 8
Gong, X., Li, C., Zhou, Z., Yu, R., Chen, Y., Tong, J., Liu, Y., Qing, T., Wu, Z., Liu, T., et al. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c06515 · Cited by 8
López, E., Etxebarria‐Elezgarai, J., García‐Sebastián, M., Altuna, M., Ecay‐Torres, M., Estanga, A., Tainta, M., López, C., Martínez‐Lage, P., Amigo, J. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094737 · Cited by 8
Liu, Y., Liu, X., Liu, Q., & Xu, T. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.343654 · Cited by 8
Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease
Zhu, G., Zhang, H., Xie, R., Younis, M. R., Fu, S., Wang, X., Liu, B., Li, K., Lui, S., & Wu, M. C. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404907 · Cited by 9
Bae, M. I., Shim, J., Lee, H. S., Jeon, S., & Kwak, Y. L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1530651 · Cited by 9
Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer’s Disease
Doskas, T. K., Vavougios, G. D., Kormas, C., Kokkotis, C., Tsiptsios, D., Spiliopoulos, K. C., Tsiakiri, A., Christidi, F., Aravidou, T., Dekavallas, L., et al. (2025) · Brain Sciences · doi:10.3390/brainsci15060564 · Cited by 11
The potential and therapeutic advances of the integrin family in neurological disorders
Zhang, X., Gao, L., Wang, Y., Meng, Q., Bai, M., Xu, D., Wang, Y., Wang, J., Bi, H., & Ding, Y. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00020 · Cited by 9
Self-citationHunter, S., Walsh, S., & Brayne, C. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03156-0 · Cited by 8
Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational study
Shah, R. C., Ryan, J. L., Webb, K. L., Wolfe, R. S., Chan, A. T., Chong, T. T. ‐., Ernst, M. E., Espinoza, S. E., Flynn, O., Lee, S. Y., et al. (2025) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2025.100764 · Cited by 7
CHI3L1: An Emerging Player in Neuroinflammation and Neurodegeneration
Mushtaq, U., Seh, B. A., Khanday, F. A., & Ahmad, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05354-x · Cited by 9
Lactate metabolism links reactive microglia, amyloid pathology, and Aβ dynamics
Ashley, C. C., Constantino, N. J., Pettit‐Mee, R. J., Snipes, J. A., Saito, K., Irmen, R. E., Zhang, R., Neary, E. M., Lanning, M. J., Karch, C. M. M., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03825-z · Cited by 7
Guardians of memory: The urgency of early dementia screening in an aging society
Hu, X., Ma, Y., Karako, K., Song, P., Tang, W., & Xia, Y. (2024) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2024.01026 · Cited by 7
Kim, S., Wang, S., Kang, D. W., Um, Y. H., Han, E. J., Park, S. Y., Ha, S., Choe, Y. S., Kim, H. W., Kim, R. E. Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147649 · Cited by 7
Self-citationWang, Y., Li, F., Qin, Q., Li, T., Wang, Q., Li, Y., Li, Y. H., & Jia, J. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100065 · Cited by 7
Self-citationHoost, S. S., Honig, L. S., Kang, M. S., Bahl, A., Lee, A., Sanchez, D. L., Reyes‐Dumeyer, D., Lantigua, R., Dage, J. L., Brickman, A. M., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100117 · Cited by 8
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance
Mirabelli, M., CHIEFARI, E. D., Arcidiacono, B., Salatino, A., Pascarella, A., Morelli, M., Credendino, S. C., Brunetti, F. S., Vito, A. D., Greco, A., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105700 · Cited by 8
Park, S., Kim, K., Yoon, S., Kim, S., Ahn, J., Lim, K. Y., Jang, H., Na, D. L., Kim, H. J., Moon, S. H., et al. (2025) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2025.24.2.135 · Cited by 7
Zhang, Q., Yu, L.-K., Zhang, X.-Y., Wu, Y., Zhang, H., Wu, J.-L., Yao, Z., & Initiative, A. D. N. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352411 · Cited by 7
Kurz, C., Alimehmeti, I., Boban, M., Kostić, S., Sinanović, O., Kučuk, O., Mehrabian, S., Traykov, L. D., Mimica, N., Novotni, G., et al. (2025) · Journal of Public Health Research · doi:10.1177/22799036251361380 · Cited by 7
Copathology in Atypical Parkinsonism—The Rule Rather Than the Exception?
Martínez-Valbuena, I., Tartaglia, M. C., Kovács, G. G., & Lang, A. E. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1630 · Cited by 9
Yang, H. J., Dong, C., Cai, Y., Zhao, M., Liu, J., Bian, S., & Ding, X. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1596459 · Cited by 8
Self-citationLuo, K., Zhang, B., Mei, Y., Rong, S., Wang, K., Liu, P., Yao, Q., He, B., Hao, B., Cheng, P., et al. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.138685 · Cited by 6
The challenging concept of preclinical Alzheimer's disease
Wallon, D., & Garnier‐Crussard, A. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.07.016 · Cited by 7
Ding, F., Jia, S., Xin, X., Li, S., Liu, C., Guo, Z., Liu, Q., Ma, X., Chen, W., & Wang, X. (2025) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-025-01803-9 · Cited by 6
The therapeutic potential of early exercise in Alzheimer's disease: Focus on the brain-spleen axis
Wang, T., Feng, L., & Tian, Z. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102980 · Cited by 6
Default mode network failure across the Alzheimer’s disease spectrum
Corriveau‐Lecavalier, N., Dicks, E., Martin, P. R., Wiste, H. J., Gunter, J. L., Kamykowski, M. G., Senjem, M. L., Schwarz, C. G., Botha, H., Graff‐Radford, J., et al. (2026) · Brain · doi:10.1093/brain/awag146 · Cited by 9
Yao, Z., Godje, I. S. G., Jiao, B., Shen, L., & Luo, S. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103153 · Cited by 6
Luo, C., Yang, T., Zhang, Y., Wu, L., Zhu, X., & Qian, Z. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.111361 · Cited by 7
Villalpando, J. M., Leclerc, B., Le, M. T., Hudon, C., Bolduc, A., & Kergoat, M. (2025) · Neuropsychology Review · doi:10.1007/s11065-025-09663-9 · Cited by 6
Bhardwaj, B., Vishwakarma, S. K., Singh, A., Kumar, H., Gajendra, T. A., Verma, A., Krishnamurthy, S., Davisson, V. J., & Shrivastava, S. K. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118047 · Cited by 6
Jiang, S., Tian, Z., Yang, Y., Li, X., Zhou, F., Cheng, J., Lyu, J., Gao, T., Zhang, P., Han, H., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.015 · Cited by 6
Self-citationJobin, B., Phillips, N. A., Frasnelli, J., Boller, B., & The CIMA-Q group (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251378386 · Cited by 7
Muir, R. T., Callum, J. L., Yu, A., Kapral, M. K., Swartz, R. H., Black, S. E., MacIntosh, B. J., Fergusson, D. A., Kleinman, S. H., Demchuk, A. M., et al. (2024) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2024.150858 · Cited by 8
Mandelblatt, J. S., Dage, J. L., Zhou, X., Small, B. J., Ahles, T. A., Ahn, J., Artese, A., Bethea, T. N., Breen, E. C., Carroll, J., et al. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae113 · Cited by 7
Wu, Q., Zhang, J., Lei, P., Zhu, X., & Huang, C. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1498636 · Cited by 6
Self-citationClinical Predictors of Cognitive Impairment in a Cohort of Patients with Older Age Bipolar Disorder
Elefante, C., Brancati, G. E., Beatino, M. F., Nerli, B. F., D’Alessandro, G., Fustini, C., Marro, D., Pistolesi, G., Baldacci, F., Ceravolo, R., et al. (2025) · Brain Sciences · doi:10.3390/brainsci15040349 · Cited by 5
Dougherty, R. J., Soldan, A., Pettigrew, C. A., Greenberg, B., Spira, A. P., Moghekar, A., & Albert, M. (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70085 · Cited by 8
Zhu, J., Xiao, X., Chen, X., Xiao, H., Tao, Z., Zhang, H., Park, K., Lam, L. Q., Thai, C., Trouson, B., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251352213 · Cited by 5
James, L. M., Stratigopoulos, G., & Georgopoulos, A. P. (2025) · Scientific Reports · doi:10.1038/s41598-025-10102-1 · Cited by 5
Jiang, Y., Ding, Y., Cao, Q., Wu, X., Li, X., Xu, Y., Zhao, Z., Xu, M., Lu, J., Wang, T., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100296 · Cited by 6
Potential diagnostic markers in Alzheimer's disease: current perspectives and future directions
Zheng, M., Wang, S., & Jia, J. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2554515 · Cited by 5
Self-citationBachmann, D., Wybitul, M., Buchmann, A., Gericke, C., Saake, A., Studer, S. T., Rauen, K., Gruber, E., Blennow, K., Zetterberg, H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70802 · Cited by 6
Béchet, S., Leonard, M. V., Ademola, E., Fritz, J. V., & Krüger, R. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-03090-z · Cited by 5
Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later
Cavaillès, C., Carnethon, M. R., Knutson, K. L., Thomas, S. M., & Yaffe, K. S. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71342 · Cited by 6
Early microglial response to amyloid plaques drives sleep loss in Alzheimer's disease
Constantino, N. J., Irmen, R. E., Lanning, M. J., Turner, S. M., Ashley, C. C., Carroll, C. M., Neary, E. M., Rubinow, D., Snipes, J. A., & Macauley, S. L. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71579 · Cited by 5
Label free, machine learning informed plasma-based elemental biomarkers of Alzheimer's disease
Safi, A., Melikechi, N., Eseller, K. E., Gaschnig, R. M., & Xia, W. (2024) · Journal of Analytical Atomic Spectrometry · doi:10.1039/d4ja00090k · Cited by 5
Obesity and brain volumes: mediation by cardiometabolic and inflammatory measures
Zhou, Q., Zhu, W., Cai, X., Jing, J., Wang, M., Wang, S., Jin, A., Meng, X., Wei, T., Wang, Y., et al. (2024) · Stroke and Vascular Neurology · doi:10.1136/svn-2023-003045 · Cited by 7
Self-citationZhang, X.-H., Tan, C., Zheng, Y.-W., Ma, X., Gong, J.-N., Tan, L., & Xu, W. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.235 · Cited by 5
Chen, L., Hu, Y., Cheng, Y., & Wang, H. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c03275 · Cited by 9
Artificial intelligence in insanity evaluation. Potential opportunities and current challenges
Scarpazza, C., & Zangrossi, A. (2025) · International Journal of Law and Psychiatry · doi:10.1016/j.ijlp.2025.102082 · Cited by 6
Yang, J., Zhang, X., Duan, L., Cheng, R., Yang, N., Peng, Z., Li, B., Xu, L., Chen, W., Chen, J., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1532080 · Cited by 5
APOE4 Increases Susceptibility to Amyloid, Accelerating Episodic Memory DeclinePreprint
Vanderlip, C. R., Stark, C. E. L., & Initiative, T. A. D. N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.23.630203 · Cited by 5
Exosomal microRNA biomarkers in Alzheimer’s disease: Systematic review and meta-analysis
Liu, S., Zhao, M., Yang, X., Liu, Y., Xu, H. E., Yan, H., & Xu, Y. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120542 · Cited by 4
EAD-net: Multi-scale wavelet mamba network for early Alzheimer’s disease diagnosis
Zhou, K., Liu, X., Liu, S., Chen, H., Zheng, Z., Luo, X., & Geng, D. (2025) · Applied Soft Computing · doi:10.1016/j.asoc.2025.114115 · Cited by 5
Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease
Wisch, J. K., McKay, N. S., Zammit, M. D., Christian, B. T., Schultz, S. A., Millar, P. R., Ryan, N. S., Cash, D. M., Belder, C. R. S., Chrem, P., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70812 · Cited by 4
Self-citationCheng, Y., Tang, L., Yi, T., Xu, H., Yang, D., Zhou, Z., Gao, W., Ke, Z., Mao, C., Hu, Z., et al. (2025) · ACS Sensors · doi:10.1021/acssensors.5c03653 · Cited by 4
Applications of Endovascular Brain–Computer Interface in Patients with Alzheimer’s Disease
Sun, Y., Chen, D., Ye, Q., You, Z., Zhao, Z., Shi, J., Sun, H., Li, S., Xu, X., Xu, Y., et al. (2025) · Research · doi:10.34133/research.1049 · Cited by 4
Fu, G., Pan, M., Sun, Q., Yue, G., & Lei, T. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101535 · Cited by 6
Advances in plasma biomarkers for the diagnosis of Alzheimer’s disease
Wu, H., Liu, L., & Zeng, L. (2026) · Brain Research · doi:10.1016/j.brainres.2025.150138 · Cited by 5
Xia, W., Xu, C., Xiao, Z., Zhou, X., Zhao, Q., Ding, D., & Deng, W. (2026) · Psychological Medicine · doi:10.1017/s0033291725103115 · Cited by 5
Hiransuthikul, A., Thanapornsangsuth, P., Luechaipanit, W., Haethaisong, T., Ubolyam, S., Apornpong, T., Han, W. M., Kerr, S. J., Avihingsanon, A., & HIV‐NAT 006 and 207 study team (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71101 · Cited by 4
Chen, S., Hao, X., Ma, K., Li, R., Wen, C., Han, X., Zheng, W., Ruan, S., You, S., An, W., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71251 · Cited by 4
Self-citationThe Gut Microbiota as a Mediator Linking the MIND Diet to Alzheimer’s Disease
Ramezani, F., Herfeh, S. S., & Burke, E. (2026) · Nutrients · doi:10.3390/nu18091445 · Cited by 5
Myrstad, C., Engdahl, B., Costafreda, S. G., Krokstad, S., Livingston, G., & Selbæk, G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14514 · Cited by 4
miR-137: A therapeutic candidate or a key molecular regulator in Alzheimer's disease?
Wasim, M., Guo, J., Wang, Z., Parveen, R., Chen, R., Wang, Y., & Ma, G. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251352166 · Cited by 5
Self-citationLiu, Z., Huang, X., Zhang, M., Quan, Y., Wang, Y., Liu, J., Nie, W., Zhao, Y., Guo, H.-Y., Quan, Z., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108866 · Cited by 4
Self-citationChasm and net: metaphors in elder-related texts in a Chinese economic newspaper
Li, K., & Zhang, Q. (2024) · Humanities and Social Sciences Communications · doi:10.1057/s41599-024-03485-5 · Cited by 4
Sun, C.-K., Guo, F., Ou, Y., Zhang, M., Tan, L., & Tan, M. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240131 · Cited by 3
Desai, U. S., Gomes, D. A., Chandler, J., Ye, W., Daly, M., Kirson, N. Y., & Dennehy, E. B. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2394602 · Cited by 4
Li, W., Fan, D., Sun, Q., Wang, L., Huang, B., Yu, Z., Tian, D., Shen, Y., Tan, C., Zeng, G., et al. (2025) · Aging Cell · doi:10.1111/acel.70036 · Cited by 3
Self-citationYu, S., Fan, J., Zong, S., Yu, Q., Cheng, Q., Wang, Y., Li, M., & Lu, Z. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2493767 · Cited by 4
Self-citationComparison of the ApoE allelic variants in the formation of intracerebral Aβ deposits
Xu, G. M., Angelle, C., Huilgol, D., Sacilotto, P., McFarland, K. N., Fromholt, S., Lopez, A., Vo, Q., Rivasplata, A., Brkic, S., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107105 · Cited by 3
Metadata
- Authors
- Jia, J., Ning, Y., Chen, M., Wang, S., Yang, H., Li, F., Ding, J., Li, Y., Zhao, B., Lyu, J., Yang, S., Yan, X., Wang, Y., Qin, W., Wang, Q., Li, Y., Zhang, J., Liang, F., Liao, Z., & Wang, S.
- Affiliations
- Capital Medical University (CN)
- From the Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital (J.J., Y.N., M.C., Shuheng Wang, H.Y., F. Li, J.D., Yan Li, B.Z., W.Q., Q.W., Ying Li), Beijing Key Laboratory of Geriatric Cognitive Disorders, Clinical Center for Neurodegenerative Disease and Memory Impairment (J.J.), the Center of Alzheimer’s Disease, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders (J.J.), and the Department of Neurology, Beijing Anding Hospital (Y.W.), Capital Medical University, Key Laboratory of Neurodegenerative Diseases, Ministry of Education (J.J.), the Center for Cognitive Disorders, Beijing Geriatric Hospital (J.L.), and the Department of Neurology, Beijing Jishuitan Hospital (X.Y.), Beijing, the Department of Neurology, Daqing Oilfield General Hospital, Daqing (S.Y.), the Department of Neurology, the 960th Hospital of the People’s Liberation Army, Jinan (J.Z.), the Department of Neurology, Baotou Central Hospital, Baotou (F. Liang), the Depa...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2024-02-22
- Volume
- 390
- Issue
- 8
- Pages
- 712-722
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4391990232
- Cited by
- 455
- References
- 33
- Citations by year
- 2026: 162 · 2025: 202 · 2024: 91
- FWCI
- 133.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (30370494, 30410303095, 30470615)
- Mission Program of Beijing Municipal Administration of Hospitals (SML20150801)
- Beijing Natural Science Foundation (7071004)
- The National Science and Technology Foundation of China (2003CB517102, 2004BA714B06-1, 2006BAI02B01, 2006CB500700, 2011CB504101, 2011ZX09307-001-03)
- Sailing Plan of Beijing Municipal Administration of Hospitals (ZY201301)
- Major project of Beijing Municipal Science and Technology Commission (D111107003111009)
- Beijing Brain Initiative from Beijing Municipal Science & Technology Commission (Z201100005520017, Z161100000216137, Z201100005520016)
- Key Project of the National Natural Science Foundation of China (81530036, U20A20354)
- National Key Scientific Instrument and Equipment Development Projects of China (31627803)
- National major R&D projects of China-Scientific technological innovation 2030 (2021ZD0201802)
- CHINACANADA Joint Initiative on Alzheimer’s Disease and Related Disorders (81261120571)
- Beijing Scholars Program
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, preclinical Alzheimer's disease, cerebrospinal fluid biomarkers, amyloid-beta 42, phosphorylated tau 181, total tau, neurofilament light chain, hippocampal volume, cognitive decline, sporadic Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Follow-Up Studies, Humans, Biomarkers, Case-Control Studies, Amyloid beta-Peptides, tau Proteins, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.